A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...

A phase 1 study of a personalized cancer vaccine demonstrated antitumor immunity in all treated patients with resected renal ...

A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...

Researchers at the Terasaki Institute for Biomedical Innovation have developed an innovative delivery system that could ...

The same mRNA technology behind COVID-19 vaccines is now being used in the fight against cancer, and the University of ...

Researchers at the Terasaki Institute for Biomedical Innovation have developed an innovative delivery system that could significantly improve the effectiveness of peptide-based cancer vaccines, ...

The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting ...

Russia cancer vaccine could receive approval by August allowing treatment to begin the head of the Gamaleya Research ...